Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain

Microbial Pathogenesis

Volumn 38, Issue 2-3, 2005, Pages 113-123

  Wormley Jr , Floyd L ^a   Cox, Gary M ^a   Perfect, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Calcineurin; Cell mediated immunity; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Meningitis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; FEMALE; FUNGAL GENE; FUNGAL STRAIN; FUNGUS MUTANT; HISTOPATHOLOGY; IMMUNE RESPONSE; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; T LYMPHOCYTE; TEMPERATURE SENSITIVITY; TH1 CELL;

FILOBASIDIELLA NEOFORMANS;

EID: 14644423252     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micpath.2004.12.007     Document Type: Article

References (52)

1. J.A. Aberg, R.W. Price, D.M. Heeren, and B. Bredt A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy J Infect Dis 185 2002 1179 1182
2. K. Aguirre, E.A. Havell, G.W. Gibson, and L.L. Johnson Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice Infect Immun 63 1995 1725 1731
3. C. Biondo, C. Beninati, D. Delfino, M. Oggioni, G. Mancuso, and A. Midiri Identification and cloning of a cryptococcal deacetylase that produces protective immune responses Infect Immun 70 2002 2383 2391
4. A. Casadevall Antibody immunity and invasive fungal infections Infect Immun 63 1995 4211 4218
5. A. Casadevall, W. Cleare, M. Feldmesser, A. Glatman-Freedman, D.L. Goldman, and T.R. Kozel Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies Antimicrob Agents Chemother 42 1998 1437 1446
6. S.L. Chuck, and M.A. Sande Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome N Engl J Med 321 1989 794 799
7. H.L. Collins, and G.J. Bancroft Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans Eur J Immunol 22 1992 1447 1454
8. V.P. Collins, A. Gellhorn, and J.R. Trimble The coincidence of cryptococcosis and disease of the reticulo-endothelial and lymphatic systems Cancer 4 1995 883 889
9. G.M. Cox, H.C. McDade, S.C. Chen, S.C. Tucker, M. Gottfredsson, and L.C. Wright Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans Mol Microbiol 39 2001 166 175
10. G.M. Cox, J. Mukherjee, G.T. Cole, A. Casadevall, and J.R. Perfect Urease as a virulence factor in experimental cryptococcosis Infect Immun 68 2000 443 448
11. R.D. Diamond, and J.E. Bennett Prognostic factors in cryptococcal meningitis Ann Intern Med 80 1974 176 181
12. W.E. Dismukes Cryptococcal meningitis in patients with AIDS J Infect Dis 157 1988 624 628
13. R. Duperval, P.E. Hermans, N.S. Brewer, and G.S. Roberts Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract Chest 72 1977 13 19
14. R.H. Eng, E. Bishburg, S.M. Smith, and R. Kapila Cryptococcal infections in patients with acquired immune deficiency syndrome Am J Med 81 1986 19 23
15. I.E. Flesch, G. Schwamberger, and S.H. Kaufmann Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans J Immunol 142 1989 3219 3224
16. D.S. Fox, M.C. Cruz, R.A. Sia, H. Ke, G.M. Cox, and M.E. Cardenas Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans Mol Microbiol 39 2001 835 849
17. A.A. Gal, M.N. Koss, J. Hawkins, S. Evans, and H. Einstein The pathology of pulmonary cryptococcal infections in the acquired immunodeficiency syndrome Arch Pathol Lab Med 110 1986 502 507
18. B.R. Gendel, M. Ende, and S.L. Norman Cryptococcosis. A review with special reference to apparent association with Hodgkin's disease Am J Med 9 1950 343 355
19. E. Goldstein, and O.N. Rambo Cryptococcal infection following steroid therapy Ann Intern Med 56 1962 114 120
20. A.C. Herring, J. Lee, R.A. McDonald, G.B. Toews, and G. Huffnagle Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection Infect Immun 70 2002 2959 2964
21. K.A. Hoag, M.F. Lipscomb, A.A. Izzo, and N.E. Street IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice Am J Respir Cell Mol Biol 17 1997 733 739
22. + T cell activation J Immunol 160 1998 4606 4614
23. G.B. Huffnagle, and M.F. Lipscomb Cells and cytokines in pulmonary cryptococcosis Res Immunol 149 1998 387 396
24. + T cells during a pulmonary Cryptococcus neoformans infection J Immunol 155 1995 4790 4797
25. G.B. Huffnagle, G.B. Toews, M.D. Burdick, M.B. Boyd, K.S. McAllister, and R.A. McDonald Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans J Immunol 157 1996 4529 4536
26. G.B. Huffnagle, T.R. Traynor, R.A. McDonald, M. Olszewski, D.M. Lindell, and A.C. Herring Leukocyte recruitment during pulmonary Cryptococcus neoformans infection Immunopharmacology 48 2000 231 236
27. W.J. Karpus, K.J. Kennedy, S.L. Kunkel, and N.W. Lukacs Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines J Exp Med 187 1998 733 741
28. K. Kawakami, X. Qifeng, M. Tohyama, M.H. Qureshi, and A. Saito Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans Clin Exp Immunol 106 1996 468 474
29. K. Kawakami, M. Tohyama, K. Teruya, N. Kudeken, Q. Xie, and A. Saito Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans FEMS Immunol Med Microbiol 13 1996 123 130
30. K. Kawakami, T. Zhang, M.H. Qureshi, and A. Saito Cryptococcus neoformans inhibits nitric oxide production by murine peritoneal macrophages stimulated with interferon-gamma and lipopolysaccharide Cell Immunol 180 1997 47 54
31. J.D. Keye, and W.E. Magee Fungal diseases in a general hospital Am J Clin Pathol 26 1956 1235 1253
32. J.A. Kovacs, A.A. Kovacs, M. Polis, W.C. Wright, V.J. Gill, and C.U. Tuazon Cryptococcosis in the acquired immunodeficiency syndrome Ann Intern Med 103 1985 533 538
33. S.M. Levitz Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans Infect Immun 59 1991 3393 3397
34. S.M. Levitz, and D.J. DiBenedetto Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans Infect Immun 56 1988 2544 2551
35. S.M. Levitz, S. Nong, M.K. Mansour, C. Huang, and C.A. Specht Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans Proc Natl Acad Sci USA 98 2001 10422 10427
36. J.L. Lewis, and S. Rabinovich The wide spectrum of cryptococcal infections Am J Med 53 1972 315 322
37. N.W. Lukacs, S.W. Chensue, W.J. Karpus, P. Lincoln, C. Keefer, and R.M. Strieter C-C chemokines differentially alter interleukin-4 production from lymphocytes Am J Pathol 150 1997 1861 1868
38. J.E. Lutz, K.V. Clemons, and D.A. Stevens Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis J Antimicrob Chemother 46 2000 437 442
39. M.A. Mandel, G.G. Grace, K.I. Orsborn, F. Schafer, J.W. Murphy, and M.J. Orbach The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice Infect Immun 68 2000 6196 6201
40. M.K. Mansour, L.E. Yauch, J.B. Rottman, and S.M. Levitz Protective efficacy of antigenic fractions in mouse models of cryptococcosis Infect Immun 72 2004 1746 1754
41. A. Matsukawa, N.W. Lukacs, C.M. Hogaboam, S.W. Chensue, and S.L. Kunkel III Chemokines and other mediators. 8. Chemokines and their receptors in cell-mediated immune responses in the lung Microsc Res Tech 53 2001 298 306
42. T.G. Mitchell, and J.R. Perfect Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans Clin Microbiol Rev 8 1995 515 548
43. C.H. Mody, C.L. Tyler, R.G. Sitrin, C. Jackson, and G.B. Toews Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity Am J Respir Cell Mol Biol 5 1991 19 26
44. J.W. Murphy, F. Schafer, A. Casadevall, and A. Adesina Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans Infect Immun 66 1998 2632 2639
45. M.C. Noverr, G.M. Cox, J.R. Perfect, and G.B. Huffnagle Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production Infect Immun 71 2003 1538 1547
46. A. Odom, S. Muir, E. Lim, D.L. Toffaletti, J. Perfect, and J. Heitman Calcineurin is required for virulence of Cryptococcus neoformans EMBO J 16 1997 2576 2589
47. P.G. Pappas, B. Bustamante, E. Ticona, R.J. Hamill, P.C. Johnson, and A. Reboli Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis J Infect Dis 189 2004 2185 2191
48. W.G. Powderly Cryptococcal meningitis and AIDS Clin Infect Dis 17 1993 837 842
49. C. Retini, T.R. Kozel, D. Pietrella, C. Monari, F. Bistoni, and A. Vecchiarelli Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans Infect Immun 69 2001 6064 6073
50. T.R. Traynor, A.C. Herring, M. Dorf, W.A. Kuziel, G.B. Toews, and G.B. Huffnagle Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity J Immunol 168 2002 4659 4666
51. A. Vecchiarelli, C. Retini, D. Pietrella, C. Monari, C. Tascini, and T. Beccari Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes Infect Immun 63 1995 2919 2923
52. L.E. Zimmerman, and H. Rappaport Occurrence of cryptococcosis in patients with malignant disease of reticuloendothelial system Am J Clin Pathol 24 1954 1050 1072